A new treatment for advanced pancreatic cancer has been approved, offering patients a more effective option. The daily medication, to be sold under a specific brand name, works by blocking a protein that fuels tumor growth. This approach has been successful in a significant percentage of cases.

Patients who took the medication saw improved survival times and experienced fewer severe side effects. The cost of a one-month supply has been announced by the company. Further details about the treatment and study results are available from the source.